Receptor–ligand analyses reveal interactions between the TIGIT receptor in lymphocytes and NECTIN ligands across all samples, which we found highly expressed in tumor cells, but somewhat less in other transitioning ductal populations (Fig. 8c and Methods). Here, NECTIN1 is linked to neoplasm.